Skip to main content
logo
Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
79.57
+1.28 (1.63%)
Oct 6, 2026, 4:00 PM EDT - Market closed

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
53443613453140
Market Cap Growth
-25.41%225.25%2552.79%-83.48%-24.23%-42.34%
Enterprise Value
400293128-31618
Last Close Price
79.5765.3022.001.7011.8516.05

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.083.172.440.913.042.13
P/TBV Ratio
4.083.172.440.913.042.13

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.00--0.00-
Net Debt / Equity Ratio
-1.02-1.02-1.09-1.30-1.30-1.07
Quick Ratio
33.4451.3311.464.144.1912.85
Current Ratio
33.5651.3511.484.174.2112.98
Return on Equity (ROE)
-19.50%-14.22%-51.42%-107.19%-72.45%-52.57%
Return on Assets (ROA)
-14.64%-10.39%-29.87%-53.66%-39.03%-30.51%
Return on Capital Employed (ROCE)
-16.90%-12.10%-29.40%-158.00%-104.30%-48.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.34%-3.14%-11.62%-166.13%-34.34%-22.52%
Buyback Yield / Dilution
-45.84%-95.53%-37.09%-8.70%-1.97%-13.82%
SEC Filings: 10-K · 10-Q